811 related articles for article (PubMed ID: 26162653)
1. Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation.
Shen JI; Montez-Rath ME; Lenihan CR; Turakhia MP; Chang TI; Winkelmayer WC
Am J Kidney Dis; 2015 Oct; 66(4):677-88. PubMed ID: 26162653
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation.
Winkelmayer WC; Liu J; Setoguchi S; Choudhry NK
Clin J Am Soc Nephrol; 2011 Nov; 6(11):2662-8. PubMed ID: 21959598
[TBL] [Abstract][Full Text] [Related]
3. Association between warfarin use and incidence of ischemic stroke in Japanese hemodialysis patients with chronic sustained atrial fibrillation: a prospective cohort study.
Wakasugi M; Kazama JJ; Tokumoto A; Suzuki K; Kageyama S; Ohya K; Miura Y; Kawachi M; Takata T; Nagai M; Ohya M; Kutsuwada K; Okajima H; Ei I; Takahashi S; Narita I
Clin Exp Nephrol; 2014 Aug; 18(4):662-9. PubMed ID: 24113782
[TBL] [Abstract][Full Text] [Related]
4. Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States.
Siontis KC; Zhang X; Eckard A; Bhave N; Schaubel DE; He K; Tilea A; Stack AG; Balkrishnan R; Yao X; Noseworthy PA; Shah ND; Saran R; Nallamothu BK
Circulation; 2018 Oct; 138(15):1519-1529. PubMed ID: 29954737
[TBL] [Abstract][Full Text] [Related]
5. Warfarin use and the risk of stroke, bleeding, and mortality in older adults on dialysis with incident atrial fibrillation.
Tan J; Bae S; Segal JB; Zhu J; Alexander GC; Segev DL; McAdams-DeMarco M
Nephrology (Carlton); 2019 Feb; 24(2):234-244. PubMed ID: 29219209
[TBL] [Abstract][Full Text] [Related]
6. Warfarin use and the risk of mortality, stroke, and bleeding in hemodialysis patients with atrial fibrillation.
Kai B; Bogorad Y; Nguyen LN; Yang SJ; Chen W; Spencer HT; Shen AY; Lee MS
Heart Rhythm; 2017 May; 14(5):645-651. PubMed ID: 28185918
[TBL] [Abstract][Full Text] [Related]
7. Apixaban Dosing Patterns Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation Receiving Dialysis: A Retrospective Cohort Study.
Wetmore JB; Weinhandl ED; Yan H; Reyes JL; Herzog CA; Roetker NS
Am J Kidney Dis; 2022 Nov; 80(5):569-579.e1. PubMed ID: 35469965
[TBL] [Abstract][Full Text] [Related]
8. Warfarin use and incidence of stroke in Japanese hemodialysis patients with atrial fibrillation.
Yodogawa K; Mii A; Fukui M; Iwasaki YK; Hayashi M; Kaneko T; Miyauchi Y; Tsuruoka S; Shimizu W
Heart Vessels; 2016 Oct; 31(10):1676-80. PubMed ID: 26646256
[TBL] [Abstract][Full Text] [Related]
9. Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis.
Tan J; Liu S; Segal JB; Alexander GC; McAdams-DeMarco M
BMC Nephrol; 2016 Oct; 17(1):157. PubMed ID: 27769175
[TBL] [Abstract][Full Text] [Related]
10. Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: A systematic review and meta-analysis.
Van Der Meersch H; De Bacquer D; De Vriese AS
Am Heart J; 2017 Feb; 184():37-46. PubMed ID: 27892885
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and outcomes of dialysis patients with atrial fibrillation: the Fushimi AF Registry.
Yamashita Y; Takagi D; Hamatani Y; Iguchi M; Masunaga N; Esato M; Chun YH; Itoh H; Nishimura M; Wada H; Hasegawa K; Ogawa H; Abe M; Akao M
Heart Vessels; 2016 Dec; 31(12):2025-2034. PubMed ID: 26973346
[TBL] [Abstract][Full Text] [Related]
12. Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Newly Diagnosed Atrial Fibrillation.
Jun M; James MT; Ma Z; Zhang J; Tonelli M; McAlister FA; Manns BJ; Ravani P; Quinn RR; Wiebe N; Perkovic V; Wilton SB; Winkelmayer WC; Hemmelgarn BR;
Am J Kidney Dis; 2017 Jun; 69(6):734-743. PubMed ID: 27998624
[TBL] [Abstract][Full Text] [Related]
13. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
[TBL] [Abstract][Full Text] [Related]
14. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
Yu AYX; Malo S; Svenson LW; Wilton SB; Hill MD
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080863
[TBL] [Abstract][Full Text] [Related]
15. Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction.
Szummer K; Gasparini A; Eliasson S; Ärnlöv J; Qureshi AR; Bárány P; Evans M; Friberg L; Carrero JJ
J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28249846
[TBL] [Abstract][Full Text] [Related]
16. Stroke, Major Bleeding, and Mortality Outcomes in Warfarin Users With Atrial Fibrillation and Chronic Kidney Disease: A Meta-Analysis of Observational Studies.
Dahal K; Kunwar S; Rijal J; Schulman P; Lee J
Chest; 2016 Apr; 149(4):951-9. PubMed ID: 26378611
[TBL] [Abstract][Full Text] [Related]
17. Warfarin Use and Increased Mortality in End-Stage Renal Disease.
Lin MC; Streja E; Soohoo M; Hanna M; Savoj J; Kalantar-Zadeh K; Lau WL
Am J Nephrol; 2017; 46(4):249-256. PubMed ID: 28910806
[TBL] [Abstract][Full Text] [Related]
18. Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoing Hemodialysis.
Coleman CI; Kreutz R; Sood NA; Bunz TJ; Eriksson D; Meinecke AK; Baker WL
Am J Med; 2019 Sep; 132(9):1078-1083. PubMed ID: 31054829
[TBL] [Abstract][Full Text] [Related]
19. Effect of oral anticoagulant therapy on mortality in end-stage renal disease patients with atrial fibrillation: a prospective study.
Genovesi S; Rebora P; Gallieni M; Stella A; Badiali F; Conte F; Pasquali S; Bertoli S; Ondei P; Bonforte G; Pozzi C; Rossi E; Valsecchi MG; Santoro A
J Nephrol; 2017 Aug; 30(4):573-581. PubMed ID: 27834042
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system.
Villines TC; Schnee J; Fraeman K; Siu K; Reynolds MW; Collins J; Schwartzman E
Thromb Haemost; 2015 Nov; 114(6):1290-8. PubMed ID: 26446456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]